This protocol is judged by an institutional critique board, an independent group that opinions any scientific trials involving humans. If a study entails a Agenda I drug, as soon as the board approves the protocol as ethical, the researchers should submit an application for an investigational new drug (IND) variety through the FDA.copyright initia